Latest papers

[Recombinant viruses of poultry as vector vaccines against fowl plague].

Differential diagnostic test technology: sensitivity and specificity, an OIE validation perspective.

Regulatory considerations for marker vaccines and diagnostic tests in the U.S.

Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.

Quality assurance/quality control of foot and mouth disease solid phase competition enzyme-linked immunosorbent assay--Part I. Quality assurance: development of secondary and working standards.

Quality assurance/quality control of foot and mouth disease solid phase competition enzyme-linked immunosorbent assay--Part II. Quality control: comparison of two charting methods to monitor assay performance.

Overview of marker vaccine and differential diagnostic test technology.

Determination of the effectiveness of Pseudorabies marker vaccines in experiments and field trials

Evaluation of the epidemiological importance of classical swine fever infected, E2 sub-unit marker vaccinated animals with RT-nPCR positive blood samples.

Candidate multi-peptide-vaccine against classical swine fever virus induced potent immunity with serological marker

A DNA vaccine expressing the E2 protein of classical swine fever virus elicits T cell responses that can prime for rapid antibody production and confer total protection upon viral challenge.

The place of marker vaccines in control and eradication of animal diseases--aspects of comparative interest.

Efficacy of E2-sub-unit marker and C-strain vaccines in reducing horizontal transmission of classical swine fever virus in weaner pigs.

Veterinary vaccines for animal and public health.

DIVA--a vaccination strategy enabling the detection of field exposure to avian influenza.

Aujeszky's disease vaccination and differentiation of vaccinated from infected pigs.

Foot-and-Mouth disease 'vaccination-to-live': possibilities and constraints.

Vaccinology of classical swine fever: from lab to field.

Generation of a candidate live marker vaccine for equine arteritis virus by deletion of the major virus neutralization domain.

[Biotechnology for the benefit of vaccination against viral diseases: a review]